InsidersTradesSigma
Browse the detailed record of transactions filed by GUSTAFSON KURT A, Chief Financial Officer. Director active across 1 companies, notably Spectrum Pharmaceuticals INC. Cumulatively, 2 disclosures have been recorded. Total volume traded: €26k. The latest transaction was filed on 15 March 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Kurt A. Gustafson is the Chief Financial Officer at SPECTRUM PHARMACEUTICALS INC. He is responsible for the financial management of the company, including financial planning, risk management, and financial reporting. His expertise is essential for ensuring the company's financial health.